Community-based management of acute malnutrition — MUAC screening, SAM/MAM triage, and RUTF outpatient recovery
Community-based Management of Acute Malnutrition (CMAM) inverted the old model of malnutrition treatment: instead of waiting for children to arrive gravely ill at a hospital, community health workers and volunteers actively search villages, markets, and homes for cases, using a tool cheap and simple enough for a minimally trained volunteer to use accurately — the MUAC tape.
Community-based Management of Acute Malnutrition (CMAM) is the WHO/UNICEF-endorsed model, developed and scaled through the 2000s famine responses in Ethiopia, Malawi, and Sudan, for treating acute malnutrition close to where children live rather than only in hospital wards.
The model rests on four pillars: (1) community outreach and mobilization so caregivers know the danger signs and where to go; (2) outpatient care for uncomplicated Severe Acute Malnutrition (SAM) using Ready-to-Use Therapeutic Food (RUTF); (3) inpatient stabilization centers (SC) for SAM with medical complications; and (4) supplementary feeding programs for Moderate Acute Malnutrition (MAM).
Before CMAM, treatment required weeks of inpatient admission to therapeutic feeding centers — a model that could reach only a small fraction of cases, since families could rarely leave home, other children, and livelihoods for a month. Outpatient RUTF treatment increased population coverage dramatically, and today CMAM-type programs have been implemented in more than 70 countries.
Before RUTF and CMAM, only about 5–10% of children with SAM ever accessed treatment. Community-based outpatient care using RUTF has pushed programme coverage above 50–70% in well-resourced responses — an order-of-magnitude jump in children reached.
Mid-Upper Arm Circumference (MUAC) is measured with a simple colour-banded, non-stretch plastic tape wrapped around the midpoint of a child's left upper arm (between the shoulder tip and elbow tip), read directly off the tape:
• Red band — MUAC <115mm — Severe Acute Malnutrition (SAM), immediate referral for treatment • Yellow band — MUAC 115–124mm — Moderate Acute Malnutrition (MAM), referral to supplementary feeding • Green band — MUAC ≥125mm — normal nutritional status
MUAC works because arm circumference reflects lean muscle and fat mass loss and is remarkably stable in length terms across ages 6–59 months, unlike weight-for-height which requires a board, scale, and trained enumerator to calculate correctly. A volunteer with a few hours of training can screen dozens of children per day at a market, mosque, church, or doorstep.
MUAC screening is also a strong predictor of mortality risk — children with MUAC <115mm have a substantially higher risk of death than children identified only by low weight-for-height, making MUAC an efficient tool for finding the children most likely to die without treatment.
Once measured, every child is sorted into one of three categories using internationally standardised cutoffs. Two independent criteria feed into the same SAM diagnosis: an anthropometric threshold (MUAC or weight-for-height Z-score) and a clinical sign — bilateral pitting edema — that overrides the numbers entirely.
A child can be diagnosed with Severe Acute Malnutrition through a route entirely separate from MUAC or weight measurements: bilateral pitting edema, the clinical hallmark of kwashiorkor (edematous malnutrition).
To test, a health worker presses a thumb gently on the top of both feet for approximately three seconds. If a pit (indentation) remains in both feet after release, the child has bilateral pitting edema and is classified as SAM regardless of how their MUAC or weight-for-height measures — even a child who looks anthropometrically "normal" on the tape can be edematous and critically ill.
Edema is graded by extent: + (both feet), ++ (feet, legs, hands, or lower arms), +++ (generalised, including face). Any grade qualifies as SAM and every edema case should, per Sphere and WHO guidance, be assessed for medical complications and considered for inpatient stabilization care given the higher mortality risk associated with kwashiorkor.
The biological mechanism differs from marasmus (wasting): kwashiorkor involves a relative deficiency of protein against energy intake, hormonal and oxidative stress responses, and fluid shifts that cause fluid to accumulate in tissue rather than pure tissue wasting — which is why weight alone can under-detect it.
A child with bilateral pitting edema is classified SAM even with a "green" MUAC reading. This is why edema checks are mandatory at every screening — MUAC tape and thumb-press edema check together, never MUAC alone.
Alongside MUAC, the WHO Child Growth Standards define acute malnutrition using Weight-for-Height Z-score (WHZ): a child's weight is compared to the median weight of a healthy reference population of the same height and sex, expressed in standard deviations (Z-scores).
• WHZ <-3 SD = Severe Acute Malnutrition • WHZ -3 to <-2 SD = Moderate Acute Malnutrition • WHZ ≥-2 SD = normal
WHZ requires a length/height board and calibrated scale plus a lookup table or app, making it slower and more resource-intensive than MUAC — it is typically reserved for clinic-based confirmation, therapeutic feeding programme admission criteria, and research, while MUAC dominates community case-finding. The two measures identify overlapping but not identical groups of children, which is why both are retained in national CMAM protocols, alongside the fully independent edema check.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Severe Acute Malnutrition (SAM) | MUAC <115mm · WHZ <-3 SD · any bilateral edema | Any one criterion alone is sufficient for SAM classification | OTP (uncomplicated) or SC (with complications/edema) |
| Moderate Acute Malnutrition (MAM) | MUAC 115–124mm · WHZ -3 to <-2 SD · no edema | Anthropometric deficit without medical danger signs | Supplementary feeding programme (fortified blended food) |
| Normal nutritional status | MUAC ≥125mm · WHZ ≥-2 SD · no edema | Growth within healthy reference range | Routine growth monitoring, no therapeutic ration |
For a child classified SAM, the single most consequential decision in the whole pathway happens next: the appetite test. It is deceptively simple — watch the child eat RUTF — yet it is the clinical gatekeeper deciding between a week of home-based treatment or admission to an inpatient stabilization center.
A child failing to finish even a small test portion of RUTF is very likely to have severe metabolic derangement, infection, or another complication that makes oral outpatient feeding unsafe — poor appetite is one of the most reliable bedside indicators of danger in a severely malnourished child, correlating with underlying complications that a rapid visual exam might miss.
The test: the child is offered a measured amount of RUTF in a calm setting, with time and coaxing from the caregiver, and the amount actually consumed is compared against a weight-based reference table. Passing means the child ate enough of the paste; failing means insufficient intake despite encouragement.
Alongside the appetite test, health workers screen for medical complications: severe bilateral pitting edema (+++), intractable vomiting, convulsions, lethargy or unconsciousness, high fever, severe dehydration, severe anemia, hypoglycemia, or hypothermia. Any one complication — regardless of appetite test result — routes the child to inpatient stabilization.
The appetite test takes only 15–30 minutes to administer but is the single decision point separating a child who goes home with a week of RUTF from one who needs F-75/F-100 therapeutic milk and 24-hour nursing in a stabilization center — getting this triage right saves both lives and scarce inpatient beds.
Outpatient Therapeutic Programme (OTP): the majority pathway for SAM without complications. The child receives a weekly RUTF ration, a basic medical check and standard medications (broad-spectrum antibiotic, vitamin A if indicated, deworming, measles vaccination if due), and returns for follow-up roughly every one to two weeks until discharge criteria are met. Treatment happens at home — protecting the caregiver's ability to look after other children and maintain the household.
Stabilization Center (SC): the inpatient pathway for SAM with medical complications or failed appetite test, or edema grade +++. Care follows the WHO 10-step management protocol: treat/prevent hypoglycemia and hypothermia, treat dehydration cautiously (malnourished children tolerate standard rehydration poorly), correct electrolyte imbalance, treat infection with antibiotics, introduce cautious feeding with F-75 therapeutic milk (formulated for stabilization, not rapid weight gain), then transition to F-100 or RUTF for catch-up growth once complications resolve — at which point many children are discharged onward into OTP to finish treatment as outpatients.
Ready-to-Use Therapeutic Food (RUTF) is the technology that made outpatient treatment of severe malnutrition possible at scale. A shelf-stable, energy-dense peanut paste that needs no water, cooking, or refrigeration, RUTF turned a hospital-bound disease into one families can treat mostly at home.
RUTF (the archetype product is Plumpy'Nut) is a lipid-based paste combining:
• Peanut paste — energy-dense fat and protein base • Milk powder (skimmed and whole) — high-quality animal protein essential for catch-up growth • Vegetable oil and sugar — concentrated calories in small volume • Vitamin and mineral premix — iron, zinc, vitamin A, iodine, and the full spectrum needed for rapid tissue repair
Each standard 92-gram sachet delivers roughly 500 kilocalories at an energy density of about 5.5 kcal/g, several times denser than typical therapeutic milks. Critically, RUTF is a low-moisture paste (water activity too low to support bacterial growth), so it requires no water for preparation, no cooking, and no refrigeration — this single property is what makes it safe to send home with a caregiver in a setting without clean water or electricity, dramatically reducing the contamination risk that plagued earlier reconstituted therapeutic milk formulas.
A typical treatment course provides roughly 150–200 kcal per kilogram of the child's body weight per day, delivered as multiple small sachets daily over the ~6–8 week course, calculated and dispensed weekly at each OTP follow-up visit.
RUTF was pioneered in the early 2000s by nutrition scientist André Briend and partners, and its no-water, no-cook, 2-year shelf-stable design is the single innovation that let treatment move out of hospital wards and into millions of homes across crisis-affected regions.
At each OTP visit — typically weekly or every two weeks — the child is weighed, re-measured by MUAC (and WHZ where feasible), checked for edema, screened again for danger signs, and given a fresh RUTF ration calculated against current body weight. This repeated measurement builds a weight-gain curve that is the core clinical tool for tracking recovery.
Expected weight gain during the RUTF phase (once acute medical issues are stable) is roughly 10–15 grams per kilogram of body weight per day — rapid catch-up growth compared to a healthy, non-malnourished child's normal growth rate. A flattening or falling curve at a follow-up visit is itself a danger sign prompting closer review, a home visit, or referral to inpatient care, even without other complications.
Ration quantity and clinical safety margins depend on reliable, continuous RUTF supply — when pipeline breaks occur (funding gaps, access constraints, conflict-driven supply interruptions), programmes are forced to ration sachets, extend the interval between visits, or use lower-cost supplementary products, all of which slow catch-up growth and increase relapse and default risk.
Recovery is defined by sustained anthropometric normalisation, not a single good measurement. Meeting the bar for discharge, and the share of children who get there, are the numbers that determine whether a therapeutic feeding programme is meeting international humanitarian standards — and whether donors and health ministries keep it funded.
A child is discharged from OTP as recovered only once anthropometric recovery is sustained, not just touched once: standard protocols require MUAC ≥125mm (or WHZ ≥-2 SD, depending on the admission criterion used) on two consecutive visits, together with the complete absence of edema and general clinical wellbeing. This "sustained" requirement guards against discharging a child on a single favourable measurement that reflects short-term fluid shifts rather than true nutritional recovery, and it substantially reduces relapse after discharge.
Outcomes other than recovery are tracked just as closely in programme monitoring: default (caregiver stops attending, commonly due to distance, competing demands, or stock-outs), non-response (no adequate progress after a defined number of weeks, triggering medical review), transfer to inpatient care, and death. The balance among these categories — not just the recovery rate alone — is what humanitarian evaluators use to judge whether a programme is functioning well.
The Sphere Handbook, the humanitarian sector's core set of minimum standards, sets explicit performance benchmarks for therapeutic feeding programmes: a recovery rate above 75%, a death rate below 10%, and a default (drop-out) rate below 15% of admissions. Well-run CMAM programmes in stable operating environments regularly meet or exceed these benchmarks; performance degrades sharply where access, security, or RUTF supply chains are disrupted.
Real humanitarian crises illustrate both the promise and the fragility of this model. The 2011 Horn of Africa famine (Somalia, Ethiopia, Kenya) drove a massive scale-up of CMAM and RUTF distribution amid one of the deadliest famines of the 21st century. In Yemen, protracted conflict since 2015 has repeatedly pushed millions of children into acute malnutrition, with access constraints and currency collapse straining OTP supply chains for years. In South Sudan, recurring conflict and flooding have kept SAM caseloads persistently high, testing programme reach in areas cut off by insecurity. In Gaza, the 2023–2024 war produced a rapid and severe deterioration in child nutritional status amid blockade and access restrictions, with humanitarian agencies reporting soaring SAM admissions and severe constraints on delivering RUTF and screening teams into affected areas — a stark illustration of how logistics and access, not just food availability, determine whether the CMAM pathway can actually reach a malnourished child in time.
In well-run OTP programmes meeting Sphere standards, recovery rates typically exceed 75% — a dramatic contrast with historical inpatient-only care, which reached only a small fraction of cases and carried far higher case-fatality rates before RUTF and community-based treatment existed.